Letter to the editor: "cyclosporin A in left ventricular remodeling after myocardial infarction".
作者信息
Javadov Sabzali
机构信息
Department of Physiology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico.
出版信息
Am J Physiol Heart Circ Physiol. 2014 Mar 1;306(5):H777. doi: 10.1152/ajpheart.00961.2013.
Abstract
摘要
相似文献
1
Letter to the editor: "cyclosporin A in left ventricular remodeling after myocardial infarction".
Am J Physiol Heart Circ Physiol. 2014 Mar 1;306(5):H777. doi: 10.1152/ajpheart.00961.2013.
2
Reply to "letter to the editor: 'cyclosporin A in left ventricular remodeling after myocardial infarction'".
Am J Physiol Heart Circ Physiol. 2014 Mar 1;306(5):H778-9. doi: 10.1152/ajpheart.00021.2014.
3
Cyclosporin A in left ventricular remodeling after myocardial infarction.
Am J Physiol Heart Circ Physiol. 2014 Jan 1;306(1):H53-9. doi: 10.1152/ajpheart.00079.2013. Epub 2013 Oct 25.
4
Cyclosporine before PCI in Acute Myocardial Infarction.
N Engl J Med. 2016 Jan 7;374(1):89. doi: 10.1056/NEJMc1514192.
5
Cyclosporine before PCI in Acute Myocardial Infarction.
N Engl J Med. 2016 Jan 7;374(1):89-90. doi: 10.1056/NEJMc1514192.
6
Cyclosporine before PCI in Acute Myocardial Infarction.
N Engl J Med. 2016 Jan 7;374(1):88-9. doi: 10.1056/NEJMc1514192.
7
Cyclosporine before PCI in Acute Myocardial Infarction.
N Engl J Med. 2016 Jan 7;374(1):88. doi: 10.1056/NEJMc1514192.
8
Cyclosporine before PCI in Acute Myocardial Infarction.
N Engl J Med. 2016 Jan 7;374(1):90. doi: 10.1056/NEJMc1514192.
9
Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling.
J Cardiovasc Electrophysiol. 2001 Sep;12(9):1055-61. doi: 10.1046/j.1540-8167.2001.01055.x.
10
Cyclosporine before PCI in Patients with Acute Myocardial Infarction.
N Engl J Med. 2015 Sep 10;373(11):1021-31. doi: 10.1056/NEJMoa1505489. Epub 2015 Aug 30.
引用本文的文献
1
Reply to "letter to the editor: 'cyclosporin A in left ventricular remodeling after myocardial infarction'".
Am J Physiol Heart Circ Physiol. 2014 Mar 1;306(5):H778-9. doi: 10.1152/ajpheart.00021.2014.
本文引用的文献
1
Cyclosporin A in left ventricular remodeling after myocardial infarction.
Am J Physiol Heart Circ Physiol. 2014 Jan 1;306(1):H53-9. doi: 10.1152/ajpheart.00079.2013. Epub 2013 Oct 25.
2
Effects of FK506 and cyclosporin a on calcium ionophore-induced mitochondrial depolarization and cytosolic calcium in astrocytes and neurons.
J Neurosci Res. 2011 Dec;89(12):1973-8. doi: 10.1002/jnr.22709. Epub 2011 Jul 11.
3
Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases.
J Pharmacol Exp Ther. 2009 Sep;330(3):670-8. doi: 10.1124/jpet.109.153213. Epub 2009 Jun 9.
4
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.
Nature. 2005 Mar 31;434(7033):652-8. doi: 10.1038/nature03317.
5
NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat.
J Mol Cell Cardiol. 2005 Jan;38(1):135-43. doi: 10.1016/j.yjmcc.2004.10.007. Epub 2004 Dec 8.
6
Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy.
Cardiovasc Res. 2002 Feb 1;53(2):294-303. doi: 10.1016/s0008-6363(01)00451-5.
7
The mechanism of action of cyclosporin A and FK506.
Immunol Today. 1992 Apr;13(4):136-42. doi: 10.1016/0167-5699(92)90111-J.
Zotero 插件